Asro

Total Flow Medical Secures FDA Clearance for Innovative TFA Cannula: A New Era in Limb Perfusion During Cardiac Surgery total-flow-medical-secures-fda-clearance-for-innovative-tfa-cannula-a-new-era-in-limb-perfusion-during-cardiac-surgery

Total Flow Medical Secures FDA Clearance for Innovative TFA Cannula: A New Era in Limb Perfusion During Cardiac Surgery

Asro August 2, 2026

In a significant development for the field of cardiovascular surgery, Total Flow Medical has announced that it...

Navigating the Unspoken: A Comprehensive Guide to Supporting Children Through a Cancer Diagnosis navigating-the-unspoken-a-comprehensive-guide-to-supporting-children-through-a-cancer-diagnosis

Navigating the Unspoken: A Comprehensive Guide to Supporting Children Through a Cancer Diagnosis

Asro August 2, 2026

A cancer diagnosis is a seismic event that reshapes the trajectory of a family’s life. While the...

Breakthrough in Brain Cancer Treatment: USC Researchers Uncover Potent Triple Therapy for Glioblastoma breakthrough-in-brain-cancer-treatment-usc-researchers-uncover-potent-triple-therapy-for-glioblastoma

Breakthrough in Brain Cancer Treatment: USC Researchers Uncover Potent Triple Therapy for Glioblastoma

Asro August 2, 2026

LOS ANGELES, CA – In a significant stride against one of the most aggressive and devastating forms...

A Fracture in Global Health: The Complex Fallout of the U.S. Withdrawal from the WHO $a-fracture-in-global-health-the-complex-fallout-of-the-u-s-withdrawal-from-the-who$

A Fracture in Global Health: The Complex Fallout of the U.S. Withdrawal from the WHO

Asro August 2, 2026

The landscape of international public health diplomacy has faced few shocks as profound as the formal notification...

A Beacon of Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership

Asro August 1, 2026

AMMAN, Jordan – The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, concluded the...

A New Frontier in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients a-new-frontier-in-medicine-crispr-based-gene-therapy-casgevy-approved-for-nhs-patients

A New Frontier in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients

Asro July 31, 2026

The landscape of modern medicine has undergone a seismic shift. For decades, individuals suffering from severe, inherited...

A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for B-Cell Lymphoma Through CAR T-Cell Therapy a-decade-of-hope-landmark-penn-medicine-study-suggests-potential-cures-for-b-cell-lymphoma-through-car-t-cell-therapy

A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for B-Cell Lymphoma Through CAR T-Cell Therapy

Asro July 31, 2026

In a medical landscape often defined by incremental progress, a decade-long study from the Abramson Cancer Center...

Bridging the Gap: Canada Establishes First National Standards for Breast Cancer Care bridging-the-gap-canada-establishes-first-national-standards-for-breast-cancer-care

Bridging the Gap: Canada Establishes First National Standards for Breast Cancer Care

Asro July 31, 2026

For decades, the Canadian healthcare landscape has been characterized by a "postal code lottery"—a system where the...

Data as a Lifeline: METAvivor Urges Congress to Bolster National Cancer Registries for 2027 data-as-a-lifeline-metavivor-urges-congress-to-bolster-national-cancer-registries-for-2027

Data as a Lifeline: METAvivor Urges Congress to Bolster National Cancer Registries for 2027

Asro July 30, 2026

In the high-stakes battle against cancer, data is not merely a collection of statistics—it is the frontline...

FDA Approves Gedatolisib (Revtorpyk) for Advanced HR-Positive/HER2-Negative Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance fda-approves-gedatolisib-revtorpyk-for-advanced-hr-positive-her2-negative-breast-cancer-a-new-paradigm-in-overcoming-endocrine-resistance

FDA Approves Gedatolisib (Revtorpyk) for Advanced HR-Positive/HER2-Negative Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance

Asro July 30, 2026

The landscape of metastatic breast cancer treatment has undergone a significant transformation with the recent U.S. Food...

Total Flow Medical Secures FDA Clearance for Innovative TFA Cannula: A New Era in Limb Perfusion During Cardiac Surgery

Navigating the Unspoken: A Comprehensive Guide to Supporting Children Through a Cancer Diagnosis

Breakthrough in Brain Cancer Treatment: USC Researchers Uncover Potent Triple Therapy for Glioblastoma

A Fracture in Global Health: The Complex Fallout of the U.S. Withdrawal from the WHO

A Beacon of Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership

A New Frontier in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients

A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for B-Cell Lymphoma Through CAR T-Cell Therapy

Bridging the Gap: Canada Establishes First National Standards for Breast Cancer Care

Data as a Lifeline: METAvivor Urges Congress to Bolster National Cancer Registries for 2027

FDA Approves Gedatolisib (Revtorpyk) for Advanced HR-Positive/HER2-Negative Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance

You may have missed

Groundbreaking Study Unveils Potent Triple-Combination Therapy, Offering Unprecedented Hope Against Aggressive Glioblastoma

Gan & Lee’s obesity drug maintains weight loss in Phase III trial

Rekindling Intimacy: Navigating Sexual Health After Breast Cancer Treatment

A Historic Victory: Africa Declared Free of Wild Poliovirus